Closing the Deal: A Cross-Cultural Comparison of Treatment Resistance

Research output: Contribution to journalArticle

Standard

Closing the Deal : A Cross-Cultural Comparison of Treatment Resistance. / Bergen, Clara; Stivers, Tanya; Barnes, Rebecca K.; Heritage, John; McCabe, Rose; Thompson, Laura; Toerien, Merran.

In: Health Communication, Vol. 33, No. 11, 02.11.2018, p. 1377-1388.

Research output: Contribution to journalArticle

Harvard

Bergen, C, Stivers, T, Barnes, RK, Heritage, J, McCabe, R, Thompson, L & Toerien, M 2018, 'Closing the Deal: A Cross-Cultural Comparison of Treatment Resistance', Health Communication, vol. 33, no. 11, pp. 1377-1388. https://doi.org/10.1080/10410236.2017.1350917

APA

Bergen, C., Stivers, T., Barnes, R. K., Heritage, J., McCabe, R., Thompson, L., & Toerien, M. (2018). Closing the Deal: A Cross-Cultural Comparison of Treatment Resistance. Health Communication, 33(11), 1377-1388. https://doi.org/10.1080/10410236.2017.1350917

Vancouver

Bergen C, Stivers T, Barnes RK, Heritage J, McCabe R, Thompson L et al. Closing the Deal: A Cross-Cultural Comparison of Treatment Resistance. Health Communication. 2018 Nov 2;33(11):1377-1388. https://doi.org/10.1080/10410236.2017.1350917

Author

Bergen, Clara ; Stivers, Tanya ; Barnes, Rebecca K. ; Heritage, John ; McCabe, Rose ; Thompson, Laura ; Toerien, Merran. / Closing the Deal : A Cross-Cultural Comparison of Treatment Resistance. In: Health Communication. 2018 ; Vol. 33, No. 11. pp. 1377-1388.

Bibtex - Download

@article{146966ff60a24a038771ca66ed38b7d5,
title = "Closing the Deal: A Cross-Cultural Comparison of Treatment Resistance",
abstract = "This study investigates patient resistance to doctors{\textquoteright} treatment recommendations in a cross-national comparison of primary care. Through this lens, we explore English and American patients{\textquoteright} enacted priorities, expectations, and assumptions about treating routine illnesses with prescription versus over-the-counter medications. We perform a detailed analysis of 304 (American) and 393 (English) naturally occurring treatment discussions and conclude that American and English patients tend to use treatment resistance in different prescribing contexts to pursue different ends. While American patients are most likely to resist recommendations for non-prescription treatment and display an expectation for prescription treatment in these interactions, English patients show a high level of resistance to recommendations for all types of treatment and display an expectation of cautious prescribing. These behavioral trends reflect broader structural forces unique to each national context and ultimately maintain distinct cultural norms of good-practice prescribing.",
author = "Clara Bergen and Tanya Stivers and Barnes, {Rebecca K.} and John Heritage and Rose McCabe and Laura Thompson and Merran Toerien",
note = "{\textcopyright} 2017 Taylor & Francis Group, LLC. This is an author-produced version of the published paper. Uploaded in accordance with the publisher{\textquoteright}s self-archiving policy. Further copying may not be permitted; contact the publisher for details",
year = "2018",
month = nov,
day = "2",
doi = "10.1080/10410236.2017.1350917",
language = "English",
volume = "33",
pages = "1377--1388",
journal = "Health Communication",
issn = "1041-0236",
publisher = "Taylor & Francis;",
number = "11",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Closing the Deal

T2 - A Cross-Cultural Comparison of Treatment Resistance

AU - Bergen, Clara

AU - Stivers, Tanya

AU - Barnes, Rebecca K.

AU - Heritage, John

AU - McCabe, Rose

AU - Thompson, Laura

AU - Toerien, Merran

N1 - © 2017 Taylor & Francis Group, LLC. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details

PY - 2018/11/2

Y1 - 2018/11/2

N2 - This study investigates patient resistance to doctors’ treatment recommendations in a cross-national comparison of primary care. Through this lens, we explore English and American patients’ enacted priorities, expectations, and assumptions about treating routine illnesses with prescription versus over-the-counter medications. We perform a detailed analysis of 304 (American) and 393 (English) naturally occurring treatment discussions and conclude that American and English patients tend to use treatment resistance in different prescribing contexts to pursue different ends. While American patients are most likely to resist recommendations for non-prescription treatment and display an expectation for prescription treatment in these interactions, English patients show a high level of resistance to recommendations for all types of treatment and display an expectation of cautious prescribing. These behavioral trends reflect broader structural forces unique to each national context and ultimately maintain distinct cultural norms of good-practice prescribing.

AB - This study investigates patient resistance to doctors’ treatment recommendations in a cross-national comparison of primary care. Through this lens, we explore English and American patients’ enacted priorities, expectations, and assumptions about treating routine illnesses with prescription versus over-the-counter medications. We perform a detailed analysis of 304 (American) and 393 (English) naturally occurring treatment discussions and conclude that American and English patients tend to use treatment resistance in different prescribing contexts to pursue different ends. While American patients are most likely to resist recommendations for non-prescription treatment and display an expectation for prescription treatment in these interactions, English patients show a high level of resistance to recommendations for all types of treatment and display an expectation of cautious prescribing. These behavioral trends reflect broader structural forces unique to each national context and ultimately maintain distinct cultural norms of good-practice prescribing.

UR - http://www.scopus.com/inward/record.url?scp=85029443652&partnerID=8YFLogxK

U2 - 10.1080/10410236.2017.1350917

DO - 10.1080/10410236.2017.1350917

M3 - Article

AN - SCOPUS:85029443652

VL - 33

SP - 1377

EP - 1388

JO - Health Communication

JF - Health Communication

SN - 1041-0236

IS - 11

ER -